Ann Arbor, MI, United States of America

Ehsan Hamtaei

This inventor holds 1 USPTO granted patent. Top assignee: Histosonics, Inc.. Active years: 2026.


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ehsan Hamtaei: Innovator in Histotripsy Technology

Introduction

Ehsan Hamtaei is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of medical technology, particularly in the development of histotripsy systems. His work focuses on creating non-invasive and minimally invasive therapeutic solutions for tissue treatment.

Latest Patents

Ehsan Hamtaei holds 1 patent for his innovative work on histotripsy systems and methods. This patent describes a histotripsy therapy system designed for the treatment of tissue. The system includes various features that enhance its efficacy in providing therapeutic, diagnostic, and research procedures. Notably, the systems and methods are capable of measuring and displaying the forces acting upon the therapy treatment head during procedures. Additionally, they account for buoyancy forces from the acoustic coupling medium.

Career Highlights

Ehsan Hamtaei is associated with Histosonics, Inc., a company dedicated to advancing the field of histotripsy technology. His role at the company has allowed him to push the boundaries of what is possible in non-invasive medical treatments. His innovative approach has garnered attention in the medical community.

Collaborations

Ehsan collaborates with Viktor Bollen, a fellow innovator in the field. Their partnership exemplifies the collaborative spirit that drives advancements in medical technology.

Conclusion

Ehsan Hamtaei's contributions to histotripsy technology represent a significant advancement in non-invasive medical treatments. His innovative systems and methods are paving the way for more effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…